EBV/HHV-6A dUTPases contribute to myalgic encephalomyelitis/chronic fatigue syndrome pathophysiology by enhancing TFH cell differentiation and extrafollicular activities.
Cox, Brandon S, Alharshawi, Khaled, Mena-Palomo, Irene et al. · JCI insight · 2022 · DOI
Quick Summary
This study found that some people with ME/CFS have abnormal immune responses linked to past infections with Epstein-Barr virus (EBV) and human herpesvirus 6A (HHV-6A). The researchers discovered that proteins from these viruses may trigger the immune system to produce excess amounts of certain signaling molecules, leading to confused immune cell behavior. This suggests a possible biological mechanism for how these common viruses might contribute to ME/CFS symptoms in some patients.
Why It Matters
This study provides a testable mechanistic pathway linking persistent EBV/HHV-6A infection to immune dysfunction in ME/CFS, potentially explaining post-infectious ME/CFS in a subset of patients. Understanding this mechanism could lead to diagnostic biomarkers and targeted therapeutic interventions. The work validates the biological plausibility of viral involvement in ME/CFS pathophysiology.
Observed Findings
Elevated serum activin A and IL-21 levels in ME/CFS cohort compared to controls
Activin A and IL-21 elevation correlated with anti-dUTPase antibody seropositivity for EBV and HHV-6A
Absence of corresponding CXCL13 elevation despite IL-21 increase
Viral dUTPases induced strong activin A secretion in in vitro studies
ME/CFS serum alone was sufficient to drive TFH cell differentiation via activin A-dependent mechanism
Inferred Conclusions
EBV and HHV-6A dUTPases abnormally enhance T follicular helper cell differentiation through activin A signaling
Impaired germinal center and extrafollicular antibody responses occur in ME/CFS due to dissociation between IL-21 and CXCL13
Viral dUTPase proteins may alter normal immune cell development and antibody generation pathways in susceptible ME/CFS patients
Abnormal germinal center activity represents a plausible mechanism linking persistent viral infection to ME/CFS pathophysiology
Remaining Questions
Is dUTPase-driven immune activation a primary cause of ME/CFS or a consequence of other pathological processes?
What This Study Does Not Prove
This study does not prove that EBV or HHV-6A directly causes ME/CFS or that dUTPases are the sole causative mechanism. The findings are correlational and based on in vitro and animal models; the causal relationship in humans remains unestablished. The study cannot determine whether dUTPase-driven immune abnormalities are a primary driver or a consequence of ME/CFS pathology.